News & AnalysisBenchling attracts $200m Series EBenchling, a life sciences R&D cloud, has raised $200 million in Series E funding.ByIris Dorbian14 April 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsTechnologyBriefs